These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Synthesis and biological activities of psi (CH2NH) pseudopeptide analogues of the C-terminal hexapeptide of neurotensin. Couder J; Tourwé D; Van Binst G; Schuurkens J; Leysen JE Int J Pept Protein Res; 1993 Feb; 41(2):181-4. PubMed ID: 8458692 [TBL] [Abstract][Full Text] [Related]
44. Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer. de Visser M; Janssen PJ; Srinivasan A; Reubi JC; Waser B; Erion JL; Schmidt MA; Krenning EP; de Jong M Eur J Nucl Med Mol Imaging; 2003 Aug; 30(8):1134-9. PubMed ID: 12768332 [TBL] [Abstract][Full Text] [Related]
45. Relationships between structure and duration of neurotensin's central action: emergence of long acting analogs. Jolicoeur FB; St-Pierre S; Aubé C; Rivest R; Gagné MA Neuropeptides; 1984 Nov; 4(6):467-76. PubMed ID: 6514148 [TBL] [Abstract][Full Text] [Related]
46. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor. Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271 [TBL] [Abstract][Full Text] [Related]
47. [Radioactive analogs of neurotensin. I. Solid phase synthesis and biological characterization of Trp 11-neurotensin, a precursor of an iodized ligand]. Labbé-Jullié C; Kitabgi P; Granier C; Vincent JP; Van Rietschoten J Biochimie; 1983 Oct; 65(10):543-51. PubMed ID: 6317061 [TBL] [Abstract][Full Text] [Related]
48. [TRP11]-neurotensin and xenopsin discriminate between rat and guinea-pig neurotensin receptors. Checler F; Labbé C; Granier C; van Rietschoten J; Kitabgi P; Vincent JP Life Sci; 1982 Sep; 31(11):1145-50. PubMed ID: 6292604 [TBL] [Abstract][Full Text] [Related]
50. Synthesis of a biologically active fluorescent probe for labeling neurotensin receptors. Faure MP; Gaudreau P; Shaw I; Cashman NR; Beaudet A J Histochem Cytochem; 1994 Jun; 42(6):755-63. PubMed ID: 8189037 [TBL] [Abstract][Full Text] [Related]
51. Structure and binding of specifically mutated neurotensin fragments on a silver substrate: vibrational studies. Podstawka-Proniewicz E; Kudelski A; Kim Y; Proniewicz LM J Phys Chem B; 2011 Jun; 115(21):7097-108. PubMed ID: 21548565 [TBL] [Abstract][Full Text] [Related]
52. Neurotensin-metabolizing peptidases in rat fundus plasma membranes. Checler F; Barelli H; Kwan CY; Kitabgi P; Vincent JP J Neurochem; 1987 Aug; 49(2):507-12. PubMed ID: 3298547 [TBL] [Abstract][Full Text] [Related]
53. Use of Molecular Modeling to Design Selective NTS2 Neurotensin Analogues. Fanelli R; Floquet N; Besserer-Offroy É; Delort B; Vivancos M; Longpré JM; Renault P; Martinez J; Sarret P; Cavelier F J Med Chem; 2017 Apr; 60(8):3303-3313. PubMed ID: 28368584 [TBL] [Abstract][Full Text] [Related]
54. Neurotensin and neurotensin receptors: characteristic, structure-activity relationship and pain modulation--a review. Kleczkowska P; Lipkowski AW Eur J Pharmacol; 2013 Sep; 716(1-3):54-60. PubMed ID: 23500196 [TBL] [Abstract][Full Text] [Related]
55. Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinus. Warner FJ; Burcher E; Carraway R; Conlon JM Peptides; 1998; 19(7):1255-61. PubMed ID: 9786176 [TBL] [Abstract][Full Text] [Related]
56. Characterization of the metabolism of substance P and neurotensin by human angiotensin I converting enzyme and "enkephalinase". Skidgel RA Prog Clin Biol Res; 1985; 192():371-8. PubMed ID: 2417254 [TBL] [Abstract][Full Text] [Related]
57. Neurotensin receptors in canine intestinal smooth muscle: preparation of plasma membranes and characterization of (Tyr3-125I)-labelled neurotensin binding. Ahmad S; Berezin I; Vincent JP; Daniel EE Biochim Biophys Acta; 1987 Jan; 896(2):224-38. PubMed ID: 3026474 [TBL] [Abstract][Full Text] [Related]